-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on HCA Healthcare, Lowers Price Target to $401

Benzinga·07/28/2025 13:44:03
Listen to the news
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $404 to $401.